Continuous flow microfluidic device for rapid erythrocyte lysis

被引:103
作者
Sethu, P
Anahtar, M
Moldawer, LL
Tompkins, RG
Toner, M [1 ]
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Surg Serv, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA
[3] Univ Florida, Coll Med, Dept Surg, Gainesville, FL 32610 USA
关键词
D O I
10.1021/ac049429p
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Leukocyte isolation from whole blood to study inflammation requires the removal of contaminating erythrocytes. Leukocytes, however, are sensitive to prolonged exposure to hyper/hypoosmotic solutions, temperature changes, mechanical manipulation, and gradient centrifugation. Even though care is taken to minimize leukocyte activation and cell loss during erythrocyte lysis, it is often not possible to completely avoid it. Most procedures for removal of contaminating erythrocytes from leukocyte preparations are designed for bulk processing of blood, where the sample is manipulated for longer periods of time than necessary at the single-cell level. Ammonium chloride-mediated lysis is the most commonly used method to obtain enriched leukocyte populations but has been shown to cause some activation and selective loss of certain cell types. The leukocyte yield and subsequent activation status of residual leukocytes after NH(4)Cl-mediated lysis have been shown to depend on the time of exposure to the lysis buffer. We have developed a microfluidic lysis device that deals with erythrocyte removal at nearly the single-cell level. We can achieve complete lysis of erythrocytes and similar to100% recovery of leukocytes where the cells are exposed to an isotonic lysis buffer for less than 40 s, after which the leukocytes are immediately returned to physiological conditions. Theoretically, this process can be made massively parallel to process several milliliterss of whole blood to obtain a pure leukocyte population in less than 15 min.
引用
收藏
页码:6247 / 6253
页数:7
相关论文
共 12 条
  • [1] CHAIYASUT C, 2001, CHROMATOGRAPHY, V23, P1
  • [2] Capillary-based fully integrated and automated system for nanoliter polymerase chain reaction analysis directly from cheek cells
    He, Y
    Zhang, YHH
    Yeung, ES
    [J]. JOURNAL OF CHROMATOGRAPHY A, 2001, 924 (1-2) : 271 - 284
  • [3] Reduced ammonium chloride haemolysis time enhances the number of isolated functional rabbit polymorphonuclear neutrophils
    Kouoh, F
    Levert, H
    Gressier, B
    Luyckx, M
    Brunet, C
    Dine, T
    Ballester, L
    Cazin, M
    Cazin, JC
    [J]. APMIS, 2000, 108 (06) : 417 - 421
  • [4] EFFECTS OF CELL PURIFICATION METHODS ON CD11B AND L-SELECTIN EXPRESSION AS WELL AS THE ADHERENCE AND ACTIVATION OF LEUKOCYTES
    MACEY, MG
    MCCARTHY, DA
    VORDERMEIER, S
    NEWLAND, AC
    BROWN, KA
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 181 (02) : 211 - 219
  • [5] MAREN TH, 1970, MOL PHARMACOL, V6, P430
  • [6] Microfluidic devices for the high-throughput chemical analysis of cells
    McClain, MA
    Culbertson, CT
    Jacobson, SC
    Allbritton, NL
    Sims, CE
    Ramsey, JM
    [J]. ANALYTICAL CHEMISTRY, 2003, 75 (21) : 5646 - 5655
  • [7] COMPARISON OF 4 LYMPHOCYTE ISOLATION METHODS APPLIED TO RODENT T-CELL SUBPOPULATIONS AND B-CELLS
    PELEGRI, C
    RODRIGUEZPALMERO, M
    MORANTE, MP
    COMAS, J
    CASTELL, M
    FRANCH, A
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 187 (02) : 265 - 271
  • [8] Cell lysis and protein extraction in a microfluidic device with detection by a fluorogenic enzyme assay
    Schilling, EA
    Kamholz, AE
    Yager, P
    [J]. ANALYTICAL CHEMISTRY, 2002, 74 (08) : 1798 - 1804
  • [9] Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V
    Tait, JF
    Smith, C
    Wood, BL
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 1999, 25 (17) : 271 - 278
  • [10] 2 METHODS FOR THE REMOVAL OF ERYTHROCYTES FROM BUFFY COATS FOR THE PRODUCTION OF HUMAN-LEUKOCYTE INTERFERON
    VANOSS, CJ
    BRONSON, PM
    DINOLFO, EA
    CHADHA, KC
    [J]. IMMUNOLOGICAL COMMUNICATIONS, 1981, 10 (06): : 549 - 555